Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non–Small-Cell Lung Cancer: Findings From a Real-Life Cohort

Autor: Dudnik, Elizabeth, Bar, Jair, Peled, Nir, Bshara, Elias, Kuznetsov, Teodor, Cohen, Aharon Yonathan, Shochat, Tzippy, Nechushtan, Hovav, Onn, Amir, Agbarya, Abed, Moskovitz, Mor, Keren, Shoshana, Popovits-Hadar, Noa, Urban, Damien, Mishaeli, Moshe, Rabinovich, Natalie Maimon, Brenner, Ronen, Zer, Alona, Rotem, Ofer, Roisman, Laila C., Wollner, Mira
Zdroj: In Clinical Lung Cancer July 2019 20(4):278-286
Databáze: ScienceDirect